+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
From
Kidney Transplant Market - Global Strategic Business Report - Product Thumbnail Image

Kidney Transplant Market - Global Strategic Business Report

  • Report
  • July 2026
  • 381 Pages
  • Global
From
From
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • July 2026
  • 196 Pages
  • Global
From
Fibrin Sealants - Global Strategic Business Report - Product Thumbnail Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • July 2026
  • 372 Pages
  • Global
From
From
From
From
Kidney Transplant Rejection - Pipeline Insight, 2026 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Loading Indicator